Cantor Fitzgerald analyst Elemer Piros raised the price target on Aldeyra Therapeutics (NASDAQ: ALDX) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Analyst PT Change Momentum Movers

Aldeyra Therapeutics (ALDX) Prices 5.25M Share Common Offering at $13.75/ShSeptember 28, 2018 5:34 AM Aldeyra Therapeutics (ALDX) Set to Up Higher by 60% Following Positive Results from Phase 2b Dry Eye Disease Clinical TrialSeptember 26, 2018 7:33 AM Aldeyra Therapeutics (ALDX) Reports Positive Results from Phase 2b Dry Eye Disease Clinical TrialSeptember 26, 2018 7:01 AM Aldeyra Therapeutics Announces Positive Results from Phase 2b Dry Eye Disease Clinical TrialSeptember 26, 2018 7:00 AM